Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Validation of Simple Quantification Methods for (18)F-FP-CIT PET Using Automatic Delineation of Volumes of Interest Based on Statistical Probabilistic Anatomical Mapping and Isocontour Margin Setting.

Kim YI, Im HJ, Paeng JC, Lee JS, Eo JS, Kim DH, Kim EE, Kang KW, Chung JK, Lee DS.

Nucl Med Mol Imaging. 2012 Dec;46(4):254-60. doi: 10.1007/s13139-012-0159-3. Epub 2012 Aug 2.

2.

Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.

Appel L, Jonasson M, Danfors T, Nyholm D, Askmark H, Lubberink M, Sörensen J.

J Nucl Med. 2015 Feb;56(2):234-42. doi: 10.2967/jnumed.114.148619. Epub 2015 Jan 15.

3.

Functional volumetric analysis of striatum using F-18 FP-CIT PET in patients with idiopathic Parkinson's disease and normal subjects.

Jeong YJ, Son HJ, Yoon HJ, Kang DY.

Ann Nucl Med. 2016 Oct;30(8):572-8. doi: 10.1007/s12149-016-1096-5. Epub 2016 Jun 9.

PMID:
27283185
4.

Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.

Kas A, Payoux P, Habert MO, Malek Z, Cointepas Y, El Fakhri G, Chaumet-Riffaud P, Itti E, Remy P.

J Nucl Med. 2007 Sep;48(9):1459-67. Epub 2007 Aug 17.

5.

Segmentation-based MR attenuation correction including bones also affects quantitation in brain studies: an initial result of 18F-FP-CIT PET/MR for patients with parkinsonism.

Choi H, Cheon GJ, Kim HJ, Choi SH, Lee JS, Kim YI, Kang KW, Chung JK, Kim EE, Lee DS.

J Nucl Med. 2014 Oct;55(10):1617-22. doi: 10.2967/jnumed.114.138636. Epub 2014 Aug 11.

6.

Comparison of the Performances of (18)F-FP-CIT Brain PET/MR and Simultaneous PET/CT: a Preliminary Study.

Kwon S, Chun K, Kong E, Cho I.

Nucl Med Mol Imaging. 2016 Sep;50(3):219-27. doi: 10.1007/s13139-016-0419-8. Epub 2016 May 6.

7.

Feasibility of PET Template-Based Analysis on F-18 FP-CIT PET in Patients with De Novo Parkinson's Disease.

Jeong E, Oh SY, Pahk K, Lee CN, Park KW, Lee JS, Cheon GJ, Choe JG.

Nucl Med Mol Imaging. 2013 Jun;47(2):73-80. doi: 10.1007/s13139-013-0196-6. Epub 2013 Mar 26.

8.

A novel, fully automated, observer-independent program for semiquantifying striatal ¹²³I-FP-CIT uptake.

Tamayo P, Montes C, Perez ME, Martin E, García-Talavera JR.

Rev Esp Med Nucl Imagen Mol. 2015 Mar-Apr;34(2):89-94. doi: 10.1016/j.remn.2014.08.004. Epub 2014 Oct 8.

9.

The Effect of SSRIs on the Binding of (18)F-FP-CIT in Parkinson Patients: A Retrospective Case Control Study.

Seo M, Oh M, Cho M, Chung SJ, Lee CS, Kim JS.

Nucl Med Mol Imaging. 2014 Dec;48(4):287-94. doi: 10.1007/s13139-014-0286-0. Epub 2014 Jul 3.

10.

Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging.

Jin S, Oh M, Oh SJ, Oh JS, Lee SJ, Chung SJ, Lee CS, Kim JS.

Nucl Med Mol Imaging. 2013 Mar;47(1):44-51. doi: 10.1007/s13139-012-0182-4. Epub 2012 Nov 3.

11.

Head-to-head comparison of 18 F-FP-CIT and 123 I-FP-CIT for dopamine transporter imaging in patients with Parkinson's disease: A preliminary study.

Lee I, Kim JS, Park JY, Byun BH, Park SY, Choi JH, Moon H, Kim JY, Lee KC, Chi DY, Kim KM, Lim I, Kang JH, Ahn SH, Kim BI, Ha JH, Lim SM.

Synapse. 2018 Feb 27. doi: 10.1002/syn.22032. [Epub ahead of print]

PMID:
29486515
12.

Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism.

Jin S, Oh M, Oh SJ, Oh JS, Lee SJ, Chung SJ, Kim JS.

Clin Nucl Med. 2017 Feb;42(2):e80-e87. doi: 10.1097/RLU.0000000000001474.

PMID:
27922865
13.

Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentation.

Bagci U, Kramer-Marek G, Mollura DJ.

EJNMMI Res. 2013 Jul 5;3(1):49. doi: 10.1186/2191-219X-3-49.

14.

Quantitative evaluation of striatal I-123-FP-CIT uptake in essential tremor and parkinsonism.

Cuberas-Borrós G, Lorenzo-Bosquet C, Aguadé-Bruix S, Hernández-Vara J, Pifarré-Montaner P, Miquel F, Álvarez-Sabin J, Castell-Conesa J.

Clin Nucl Med. 2011 Nov;36(11):991-6. doi: 10.1097/RLU.0b013e3182291a7b.

PMID:
21975386
15.

Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.

Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AG, Stoof JC, van Royen EA.

J Nucl Med. 1998 Nov;39(11):1879-84.

16.

Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.

Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, Moon DH, Oh SJ, Chung SJ, Lee CS.

J Nucl Med. 2012 Mar;53(3):399-406. doi: 10.2967/jnumed.111.095224. Epub 2012 Feb 9.

17.

Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.

Kim JS, Cho H, Choi JY, Lee SH, Ryu YH, Lyoo CH, Lee MS.

PLoS One. 2015 Jul 6;10(7):e0132585. doi: 10.1371/journal.pone.0132585. eCollection 2015.

18.

Creation and validation of an I-123 FP-CIT template for statistical image analysis using high-resolution SPECT for parkinsonian patients.

Hida K, Nonokuma M, Kuwabara Y, Tani T, Takano K, Yoshimitsu K.

Ann Nucl Med. 2016 Aug;30(7):477-83. doi: 10.1007/s12149-016-1085-8. Epub 2016 May 25.

19.

Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.

Meyer PT, Winz OH, Dafotakis M, Werner CJ, Krohn T, Schäfer WM.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):301-9.

PMID:
21532542
20.

Uneven age effects of [(18)F]FP-CIT binding in the striatum of Parkinson's disease.

Lee CS, Kim SJ, Oh SJ, Kim HO, Yun SC, Doudet D, Kim JS.

Ann Nucl Med. 2014 Nov;28(9):874-9. doi: 10.1007/s12149-014-0882-1. Epub 2014 Jul 10.

PMID:
25008292

Supplemental Content

Support Center